Karnataka cancels 16 pharmacy licenses and seizes counterfeit medicines worth over five crores.

The seized stock included 5,640 vials of CEFIAVIGENT 2.5 Injection, 1,531 vials of HIZLAM Injectables and 264 vials of EMBLAVEO carrying a Pfizer label, alongside 30 boxes of expired medicines.
The seized medicines could contain no active pharmaceutical ingredients, incorrect ingredients or harmful substances, according to the FDA, which warned that they posed a serious public-health risk.
The offences are being pursued under Sections 17B and 27 of the Drugs and Cosmetics Act, which classify counterfeit medicines as spurious drugs and provide for rigorous imprisonment and fines for their manufacture, sale, stocking or distribution.
The state formed an SIT headed by IPS officer C. Vamsi Krishna after the preliminary findings indicated a potentially wider network. Health Minister U.T. Khader said Pfizer’s sales in Karnataka had been stopped because the company allegedly did not cooperate with the investigation.
Authorities blocked the relevant drug batch numbers on the FDA portal to prevent further sale or distribution while samples undergo testing for chemical composition, sterility and potency.
Karnataka's drug regulator shut down 16 pharmacies and suspended eight others after busting a massive counterfeit medicine operation. The South First reported that officials raided a farmhouse in Bidadi on August 18 and seized fake injectable drugs relabelled as expensive brands like Pfizer, along with forged labels and printing machines worth ₹5.05 crore. The counterfeit medicines could contain no active ingredients, wrong ingredients, or harmful substances — posing serious risks to patients who took them.
The seizure included 5,640 vials of CEFIAVIGENT injection, 1,531 vials of HIZLAM injectables, and 264 vials carrying fake Pfizer labels, Times of India reported. The fake labels had QR codes that failed verification tests. Authorities also suspended Pfizer's distribution depot in Nelamangala, and a state investigation team is now tracking the wider supply chain to find other contaminated batches.
Investigators discovered an unlicensed facility at a Bidadi farmhouse where criminals repackaged and relabelled cheap drugs as costly multinational products. Rediff noted that the operation involved both manufacturing and trading of spurious medicines by multiple retailers and wholesalers across Karnataka. The gang used professional printing materials and machinery to create fake labels that mimicked real pharmaceutical packaging, fooling customers into buying counterfeit injectables.
The fake products were designed to look identical to genuine medicines sold by big brands. Criminals printed fake QR codes on the labels to appear legitimate, but India Today confirmed these codes failed verification when scanned. The operation suggests an organized network moving counterfeit stock through multiple distributors and retailers across the state.
The seized counterfeit medicines pose extreme dangers to patients. Varthabhrati reported that the fake drugs could contain no active pharmaceutical ingredients whatsoever, incorrect ingredients, or toxic substances. Samples are undergoing laboratory tests to determine exact composition, potency, and sterility. If patients injected these unknown substances, they risked infections, allergic reactions, and treatment failure for their underlying illnesses.
The raid also recovered 30 boxes of expired medicines that were being repackaged with new dates. Times of India said authorities immediately blocked all affected batch numbers on the FDA database to prevent further sales. This stopped the contaminated drugs from reaching hospitals, clinics, and pharmacies still holding inventory from the criminal network.
Authorities registered a criminal case under the Drugs and Cosmetics Act, which treats counterfeit medicines as serious crimes. The South First reported that violations fall under Sections 17B and 27, which carry rigorous imprisonment and heavy fines for manufacturing, selling, stocking, or distributing spurious drugs. The state health minister said Pfizer's sales were halted statewide because the company allegedly did not cooperate with the investigation into its depot's alleged links to the distribution network.
A special investigation team headed by IPS officer C. Vamsi Krishna was formed to track the supply chain and identify other locations involved in the racket. Officials worry the counterfeit operation extended beyond what the initial raid uncovered, potentially placing thousands of patients at risk across Karnataka and neighboring states. Laboratory testing continues on all seized samples to document the exact composition and danger level of each fake product.
Publishers
16
Articles
8
Reach
24